Zobrazeno 1 - 10
of 10
pro vyhledávání: '"D E, Boag"'
Publikováno v:
Journal of Lipid Research, Vol 26, Iss 9, Pp 1058-1067 (1985)
The conversion of very low density (VLDL) to low density lipoproteins (LDL) is a two-step process. The first step is mediated by lipoprotein lipase, but the mechanism responsible for the second is obscure. In this study we examined the possible invol
Externí odkaz:
https://doaj.org/article/002c8ce688f7422e8b6656e92880a001
Publikováno v:
Journal of Lipid Research, Vol 24, Iss 5, Pp 588-595 (1983)
This study examines the effects of probucol (1 g/day) on the plasma concentration, composition, and metabolism of low and high density lipoproteins (LDL and HDL) in eleven hyperlipidemic subjects, (seven Type II and four Type IV). The drug lowered pl
Externí odkaz:
https://doaj.org/article/7359d364b9cc4014afc6e68854c5e59b
Publikováno v:
Clinical Chemistry. 40:758-762
The limitation of plasma sodium concentration as an indicator of extracellular hydration status in cases of acute diabetes is well recognized and could lead to individually inappropriate fluid therapy. However, in view of the small analytical and bio
Publikováno v:
QJM : monthly journal of the Association of Physicians. 99(6)
Nephrologists have long been concerned about late referral of patients with severe kidney disease, and resultant poor outcomes on dialysis. But there is an increasing realisation that mild to moderate chronic kidney disease is far more common than pr
Publikováno v:
Clinical chemistry. 40(5)
The limitation of plasma sodium concentration as an indicator of extracellular hydration status in cases of acute diabetes is well recognized and could lead to individually inappropriate fluid therapy. However, in view of the small analytical and bio
Autor:
D Ballantyne, A. R. Lorimer, D E Boag, J M Stewart, Christopher J. Packard, H G Morgan, R S Clark, R F Atmeh, Kay Carr, J. Shepherd
Publikováno v:
Journal of Clinical Investigation. 74:2164-2177
This study describes the effects of bezafibrate, an analogue of clofibrate, on the plasma lipid and lipoprotein profiles of 11 hypertriglyceridemic subjects and on their metabolism of apolipoproteins A-I, A-II, and B. The major action of the drug was
Publikováno v:
Journal of Lipid Research, Vol 26, Iss 9, Pp 1058-1067 (1985)
The conversion of very low density (VLDL) to low density lipoproteins (LDL) is a two-step process. The first step is mediated by lipoprotein lipase, but the mechanism responsible for the second is obscure. In this study we examined the possible invol
Publikováno v:
Atherosclerosis. 44(3)
This study examines the effects of bezafibrate (200 mg t.i.d.) on LDL metabolism in 7 type II hyperlipoproteinaemic subjects. Eight weeks of treatment lowered plasma cholesterol and triglyceride by 10% and 30%, respectively (P less than 0.02). These
Publikováno v:
Biochemical Society Transactions. 9:211P-211P
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 26:207-207